Abstracts

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30 Wed, Oct 01

Sunday, September 28

5:15 PM - 5:25 PM PT

174 - Long-Term Failure Patterns and Prognostic Factors in a Randomized Dose-Escalation Trial for Skull Base Chordomas: A Secondary Analysis from PROG 85-26.
Speaker: Ioakeim-Ioannidou, Myrsini, MD - Massachusetts General Hospital, Boston, MA
5:25 PM - 5:35 PM PT

144 - Early Outcomes of a Phase III Randomized Controlled Trial Comparing Ultra-Hypo Fractionated 5 Fraction Treatment vs. Hypofractionated 15 Fraction Treatment for Patients Receiving Regional Nodal Irradi
Speaker: Vargas, Carlos, MD - Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ
5:25 PM - 5:35 PM PT

150 - Safety and Efficacy of POstoPerative Ablative RadioTherapy (POPART) for Post-Prostatectomy Biochemical Recurrence
Speaker: Ferrario, Federica, MD - University of Milan Bicocca - School of Medicine and Surgery, Milan
5:25 PM - 5:35 PM PT

156 - Long-Term Outcomes Following Substantial De-Escalation of Elective Radiotherapy Dose and Volume in Patients Treated with Definitive Chemoradiotherapy for HPV-Associated Oropharyngeal Cancer
Speaker: Safavi, Amir, MD, MSc - Memorial Sloan Kettering Cancer Center, New York, NY
5:25 PM - 5:35 PM PT

162 - Is Patient-Reported Baseline Fatigue Associated with Overall Survival Among Patients with Resected Head of the Pancreas Adenocarcinoma on NRG Oncology/RTOG 0848?
Speaker: Kachnic, Lisa, MD, FASTRO - Columbia University Medical Center, New York, NY
5:25 PM - 5:35 PM PT

169 - Automating Head-and-Neck Cancer Intensity Modulated Radiation Therapy Treatment Planning with a ReAct Large Language Model Agent
Speaker: Yang, Dongrong, MS, BS - Duke University Medical Center, Durham, NC
5:25 PM - 5:35 PM PT

175 - Surgical Graft and Flap Toxicity Following Hypofractionated Adjuvant Radiotherapy for Primary Cutaneous Melanoma
Speaker: Yang, Noel, MS - MD Anderson Cancer Center, Houston, TX
5:35 PM - 5:45 PM PT

145 - Ultra-Hypofractionated Partial Breast Re-Irradiation for Ipsilateral Breast Cancer Recurrence
Speaker: Nassif, Tracy, MD - Corewell Health William Beaumont University Hospital, Royal Oak, MI
5:35 PM - 5:45 PM PT

151 - Bladder Only vs. Whole Pelvis Radiotherapy in Trimodality Treatment for Lymph Node Negative Urothelial Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis
Speaker: Granda, Alyssa Anne - Jose R. Reyes Memorial Medical Center, Manila
5:35 PM - 5:45 PM PT

151 - Bladder Only vs. Whole Pelvis Radiotherapy in Trimodality Treatment for Lymph Node Negative Urothelial Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis
Speaker: Granda, Alyssa Anne - Jose R. Reyes Memorial Medical Center, Manila
5:35 PM - 5:45 PM PT

157 - A Multi-Site Single-Arm Phase I/II Trial of Selective Avoidance of Nodal VolumEs at Minimal Risk (SAVER) in the Contralateral N0 Neck of Patients with p16-Positive Oropharynx Cancer
Speaker: Molitoris, Jason, MD, PhD - University of Maryland School of Medicine, Baltimore, MD
5:35 PM - 5:45 PM PT

163 - Real World Validation of a Head and Neck Specific Patient-Reported Outcome CTCAE Measure in a Radiation Oncology Clinic
Speaker: Razavian, Niema, MD - Moffitt Cancer Center, Tampa, FL